There's More Than Meets the Eye To CDC's April 20th Press Conference
Craig Maupin at
http://www.cfidsreport.com
In certain circumstances, silence can be refreshing. In other circumstances, silence can be uncomfortable. At a recent press conference on April 20th, 2006, Centers for Disease Control (CDC) researchers laid out their plans for the future of chronic fatigue syndrome (CFS) research and clinical care. For several days following the press conference, the CFS community was remarkably silent -- uncomfortably silent.
The press conference generated the most publicity CFS has seen in the last 20 years, as major networks and over 400 newspapers carried the rearchers had uncovered "groundbreaking
results" which prove CFS has a "biological basis" as a cumulative,
post-stress disorder. CDC researchers also affirmed that some CFS sufferers are "as impaired as a whole as people with MS, as people with AIDS, as people undergoing chemotherapy for cancer". According to Dr. William Reeves, who directs the CFS program, the CDC will soon fund a provider education program designed so "providers, medical schools, and insurance providers get this more into their mainstream."
CFS advocacy groups have long complained that the federal government has not funded enough research, created enough media attention, or discovered effective treatments. But if the CDC's press conference fulfilled these requests, why weren't CFS sufferers breaking out in a collective celebration? Why weren't most advocates cheering the positive culmination of years of political requests for "more"?
Thursday, April 20th marks an attempt to shift the way chronic fatigue syndrome will be conceptualized - by scientists, physicians, and the public. The Centers for Disease Control is esteemed to be medicine's "Seal of Approval". More importantly, Reeve's cards, which have been painstakingly held close to his chest over the years, are finally on the table. On Thursday, Reeves and his allies appeared to be playing those cards in an attempt to sway public opinion and policy.
Despite the spin about "biology", the three genes which Dr. William Reeves claims will direct future research and clinical care for CFS are primary to the biological footprint of post-traumatic stress disorder and anxiety. Reeves claims a recent study's outcome has alerted the Centers for Disease Control to the importance of stress response in the pathophysiology of CFS. In the study, abnormal expression of genes involving stress were uncovered in a broad array of research samples which included people with fatigue, CFS, and other unexplained conditions. And
now, CDC researchers insist the study will change the way CFS is handled clinically by physicians, scientists, and insurers - very soon.
The CDC is well-positioned to enact this shift. At the moment, they possess a strong facade of flawed, yet "empirical", evidence. Reeves has also worked diligently to build strong financial and philosophical ties to advocacy leaders who are eager to assist his efforts. But more importantly, the CDC team is well-versed in the technical, yet gentle, terminology that can help move their ideas forward politically and socially. Terms like "biologically-based", "genetic predisposition", "homeostatic imbalance", "glucocorticoid receptors", and "allopathic load' assuage many CFS sufferers to a new post-traumatic stress disorder. Reeves made use of that knowledge on Thursday.
What didn't find its way into newsprint about the CDC's announcement was the collective concern of the CFS community. Most CFS sufferers viewed the announcement as a hallmark event in a long list of disappointments. They know they face a complex set of problems. And currently, they realize that there is little or no organized advocacy efforts in the U.S. addressing these issues. What are the problems?
First, the CDC's Wichita CFS research subjects don't appear to be very disabled. At the press conference, Reeves touted the fact that 84 percent of the Wichita samples his staff had evaluated to have CFS didn't even know they had any illness, much less chronic fatigue syndrome. And according to a CDC study published in 2003, the average combined workload (employment and chores) of those diagnosed with CFS by the CDC's research definition was close to 48 hours per week. Apparently, these Wichita CFS sufferers, diagnosed by using the CDC's 1994 research definition, are running circles around many healthy people.
In 1994, the CDC merged fatiguing conditions such as anxiety, sleep disorders, and fibromyalgia into the CFS research rubric, an approach which was favored by those who hastily espoused a psychiatric model for CFS. But questions remain as to whether this "integrative approach" is muddying, rather than clarifying, research results? Many CFS advocates feel the freewheeling approach has simply made their illness vanish. To them, the CDC is now left finding common markers for a wide variety of fatiguing disorders - an understandable outcome for an illness is named after a common human experience of "fatigue". The construct of CFS no longer serves who it was meant to serve.
Secondly, CFS sufferers are deeply concerned about the objectivity of the government agencies charged with researching CFS. As early as 1995, Reeves claimed that the distinguishing feature of CFS was "multiple major lifetime stresses in the year before one becomes ill." Since his 1995 comment, Reeves surrounded himself with researchers who seemed to share his early viewpoint. At the 2004 Oct 8-14 AACFS conference, Dr. James
Jones (widely considered Reeves right-hand man) postulated the idea that the CDC believed CFS may be a severe form of post-traumatic stress and fear/avoidance. Reeves most visible collaborations for years have been with a group of researchers who specialize in post-stress disorders at the Emory University Department of Psychiatry and Behavioral Sciences (Raison, Heim,
Miller). Reeves has since been named an adjunct professor of psychiatry at Emory University, a position for which Reeves has seemingly has few qualifications.
However, the most disheartening aspect of the Reeve's recent announcement was simply his decision to make the announcement at this time. Why declare that stress and post-trauma response will be the primary emphasis of future clinical care and research for CFS? Reeves clearly stated that policy would be based on a recent study designed so ONLY genetic snips pertaining to the HPA axis (which pertains to the biology of emotions and stress response) would receive consideration. Wouldn't it be more responsible, from a scientific and social perspective, to wait until a study was completed which could be designed to test the entire genome? Sadly, this question doesn't have a good answer. Even worse, it isn't being asked by those who should be asking it.
Admittedly, a small group of CFS advocates have hailed the CDC's push to shift CFS research and clinical care in a new -- more narrow -- direction. CFIDS Association of America director Kimberly McCleary said the findings contribute to an evolving, yet complicated, explanation of how genes, stress and other factors work together to cause and perpetuate the illness. Dr. Lucinda Bateman, a CAA board member, added, "This is a very important foundation for developing new treatments".
I would love to share their optimism. Yet, are these comments the voice of the CAA's contracts with the CDC, or are they the voice of those who suffer from CFS? As I perused a recent "Research Edition" from the CFIDS Association of America (CAA) this spring, I couldn't help but be saddened by the beliefs about CFS which were evident therein. If you profess to be a strong and principled CFS advocate, yet you decide to portray CFS as a sleep disorder, "genetic predisposition" to "misperceive" symptoms, or post-stress response, are you an effective advocate? Unfortunately, those who have supported this approach, financially and otherwise, have done more harm to CFS sufferers than good. A strong salary, a regional clinical center, or a deep bank account are not the most valuable assets any advocacy organization possesses. Because CFS is an illness which has been at the center of an ideological and political tug-of-war, it is quality and principles that matter most, not the "more".
I started the CFIDS Report several years ago because I wanted to create a haven from the controversy, anger, and divisiveness that often surrounds CFS. Yet, to place a positive spin on the developments of April 20th, 2006 would be insincere. Research, clinical care, and advocacy efforts for those with CFS will be adversely affected. And when a reliable, professional, and diplomatic voice was needed to articulate why CFS could be conceptualized outside Reeve's paradigm, the CFS community did
not have a leader who could act in that capacity.
I know those who will be negatively affected by recent events. They are my friends. They are my fellow community. Unlike the CFS samples in the CDC's Wichita dataset, they are unable to work 48 hours a week. On Thursday, April 20th, they reacted to the CDC's news about CFS with silence. But perhaps it was this silence, inaction, and a collective inability to address mounting problems that was the most disheartening news of all.